로딩 중…
지수 로딩 중…
Edgewise Therapeutics, Inc.
EWTX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$38.38-0.13%
2026-08-03
Financials
Valuation Metrics
Edgewise Therapeutics, Inc.'s Market Cap is $4.13B. At end of 2025 it was $2.55B. Ranked #1534 of 3,112 in US market (top 49%), #532 of 1,445 on NASDAQ (top 37%), #88 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 33%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $4.13B | US#1,534/3,112 Sec#88/269 |
| Revenue | $0.00 | US#2,974/3,112 Sec#204/269 |
| Net Income | $-176M | US—/3,112 Sec—/269 |
| Total Assets | $519M | US#2,726/3,112 Sec#151/269 |
| Net Assets | $493M | US#2,272/3,112 Sec#115/269 |
| Value | ||
| P/B | 8.37x | US#2,522/3,112 Sec#196/269 |
| FCF Yield | -3.60% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -35.69% | US#2,660/3,112 Sec#140/269 |
| ROA | -33.94% | US#2,895/3,112 Sec#172/269 |
| Financial Health | ||
| Debt Ratio | 5.13% | US#50/3,112 Sec#20/269 |
| Total Debt | $4M | US#2,872/3,112 Sec#222/269 |
| FCF | $-149M | US#2,680/3,112 Sec#190/269 |
| Cash | $33M | US#2,737/3,112 Sec#249/269 |
| Current Ratio | 22.61x | US#111/3,112 Sec#24/269 |
| Performance | ||
| 1Y Return | 168.20% | US#118/3,112 Sec#43/269 |
| 1M Return | -2.98% | US#2,026/3,112 Sec#103/269 |
| From 52W High | -20.70% | US#1,758/3,112 Sec#112/269 |
| 1Y MDD | -21.01% | US#770/3,112 Sec#34/269 |
| Trading | ||
| Volume | 644,287 shares | US#1,872/3,112 Sec#184/269 |
| Trading Value | $24M | US#1,855/3,112 Sec#132/269 |
| Per Share | ||
| EPS | $-1.63 | US—/3,112 Sec—/269 |
| BPS | $5.07 | US#2,223/3,112 Sec#132/269 |